share_log

BioVie | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

BioVie | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

BioVie | S-1/A:证券上市注册声明(修正)
美股SEC公告 ·  2024/11/27 12:18

Moomoo AI 已提取核心信息

On November 27, 2024, BioVie filed Amendment No. 1 to its Form S-1 Registration Statement with the SEC. This amendment was made to correct a scrivener's error in Exhibit 5.1 regarding the aggregate total being registered. The amendment includes only the facing page, explanatory note, Item 16(a) of Part II, the signature page, and the corrected Exhibit 5.1. The rest of the Registration Statement remains unchanged. BioVie is classified as a non-accelerated filer and a smaller reporting company. The company has not elected to use the extended transition period for complying with new or revised financial accounting standards. The registration statement will become effective as determined by the SEC under Section 8(a) of the Securities Act of 1933.
On November 27, 2024, BioVie filed Amendment No. 1 to its Form S-1 Registration Statement with the SEC. This amendment was made to correct a scrivener's error in Exhibit 5.1 regarding the aggregate total being registered. The amendment includes only the facing page, explanatory note, Item 16(a) of Part II, the signature page, and the corrected Exhibit 5.1. The rest of the Registration Statement remains unchanged. BioVie is classified as a non-accelerated filer and a smaller reporting company. The company has not elected to use the extended transition period for complying with new or revised financial accounting standards. The registration statement will become effective as determined by the SEC under Section 8(a) of the Securities Act of 1933.
2024年11月27日,BioVie向美国证券交易委员会提交了其S-1表格注册声明的第1号修正案。该修正案旨在更正附录5.1中抄写员关于注册总额的错误。修正案仅包括对页、解释性说明、第二部分第16(a)项、签名页和更正后的附录5.1。注册声明的其余部分保持不变。 BioVie被归类为非加速申报人和规模较小的申报公司。该公司没有选择使用延长的过渡期来遵守新的或修订的财务会计准则。注册声明将根据美国证券交易委员会根据1933年《证券法》第8(a)条的规定生效。
2024年11月27日,BioVie向美国证券交易委员会提交了其S-1表格注册声明的第1号修正案。该修正案旨在更正附录5.1中抄写员关于注册总额的错误。修正案仅包括对页、解释性说明、第二部分第16(a)项、签名页和更正后的附录5.1。注册声明的其余部分保持不变。 BioVie被归类为非加速申报人和规模较小的申报公司。该公司没有选择使用延长的过渡期来遵守新的或修订的财务会计准则。注册声明将根据美国证券交易委员会根据1933年《证券法》第8(a)条的规定生效。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息